IP Library Granted Patent US 11,685,758
Granted Patent B2
US 11,685,758 · App. 17/053,317 · Granted Jun 27, 2023

Simple method for the purification of lacto-N-neotetraose (LNnT) from carbohydrates obtained by microbial fermentation

Inventors: Stefan Jennewein (Bad Honnef, DE); Markus Helfrich (Bad Hoenningen, DE)
Assignee: Chr. Hansen HMO GmbH
C07H1/08C07H3/06C12N9/1051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,685,758
App. No.
17/053,317
Granted
Jun 27, 2023
Kind
B2
Abstract

Provided is a method for the purification of lacto-N-neotetraose from other carbohydrates, characterized in that the method comprises the steps of subjecting an aqueous solution containing lacto-N-neotetraose to two membrane filtration steps using different membranes or of subjecting an aqueous solution containing lacto-N-neotetraose to a membrane filtration step and a continuous chromatography.

Claims (14)

1. A method for purification of lacto-N-neotetraose from other carbohydrates, wherein the lacto-N-neotetraose is produced by microbial fermentation and wherein the method comprises:

a) separating biomass from a microbial fermentation broth comprising lacto-N-neotetraose to obtain a cell-free fermentation broth comprising lacto-N-neotetraose;

b) subjecting the cell-free fermentation broth to ion-exchange resin treatment to remove charged material, wherein the cell-free fermentation broth is treated with a cation exchange resin and an anion exchange resin to obtain an aqueous solution comprising lacto-N-neotetraose;

c) subjecting the aqueous solution comprising lacto-N-neotetraose obtained in step b) to:

i) a first membrane filtration step to remove carbohydrates having a molecular weight smaller than that of lacto-N-neotetraose, wherein the first membrane is selected from a molecular weight cut-off of between about 300 and about 500 Dalton;

ii) a second membrane filtration step to remove carbohydrates having a molecular weight larger than that of lacto-N-neotetraose, wherein the second membrane is selected from a molecular weight cut-off of between about 600 and about 800 Dalton, and

d) a step for increasing the concentration of the lacto-N-neotetraose present in the filtrate of step c).

2. The method according to claim 1 , wherein separating the biomass from the fermentation broth comprises a step of at least one ultrafiltration, of two ultrafiltrations, or of a first ultrafiltration using a membrane having a molecular weight cut-off of about 500 kDa and a second ultrafiltration using a membrane having a molecular weight cut-off of about 150 kDa.

3. The method according to claim 1 , wherein the cation exchange resin is in H + form, and the anion exchange resin is in Cl − form.

4. The method according to claim 1 , wherein the method further comprises dialysis or electrodialysis.

5. The method according to claim 1 , wherein the purity of lacto-N-neotetraose in the aqueous solution is ≤70%, ≤60%, ≤50%, ≤40%, ≤30%, ≤20%, ≤10%, or ≤5% with respect to areas of peaks of a HPLC chromatogram prior to purification and/or the aqueous solution contains lacto-N-neotetraose at a purity of ≥80%, ≥85%, or ≥90% with respect to areas of peaks of a HPLC chromatogram after purification.

6. The method according to claim 1 , wherein the method further comprises using at least one glycosidase for hydrolyzing one or more carbohydrates other than LNnT in the microbial fermentation broth.

7. The method according to claim 1 , wherein a second microorganism is added to the microbial fermentation broth after fermentative production of LNnT, wherein said second microorganism expresses a β-galactosidase, and/or a N-acetylhexosaminidase.

8. The method according to claim 7 , wherein the β-galactosidase is encoded by E. coli lacZ, and/or the N-acetylhexosaminidase is encoded by bbhl of B. bifidum.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Apr 6, 2022
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 059617/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2021
From: JENNEWEIN, STEFAN; HELFRICH, MARKUS
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 055723/0139 →
Priority Claims (1)
EP 18171114 · May 7, 2018 · regional
Continuity (1)
Related Publication 20210230199A1 · Jul 29, 2021